Engineering a Replication-Competent, Propagation-Defective Middle East Respiratory Syndrome Coronavirus as a Vaccine Candidate
暂无分享,去创建一个
I. Sola | L. Enjuanes | F. Almazán | S. Zúñiga | G. Andrés | M. DeDiego | Jose L Nieto-Torres | Silvia Márquez-Jurado
[1] T. Bestebroer,et al. MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-α treatment , 2013, The Journal of general virology.
[2] D. Cummings,et al. Hospital outbreak of Middle East respiratory syndrome coronavirus. , 2013, The New England journal of medicine.
[3] Yi Shi,et al. Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26 , 2013, Nature.
[4] Juan Carlos Oliveros,et al. Alphacoronavirus Protein 7 Modulates Host Innate Immune Response , 2013, Journal of Virology.
[5] Lu Lu,et al. Middle East respiratory syndrome coronavirus (MERS-CoV): challenges in identifying its source and controlling its spread , 2013, Microbes and Infection.
[6] B. Bosch,et al. The Receptor Binding Domain of the New Middle East Respiratory Syndrome Coronavirus Maps to a 231-Residue Region in the Spike Protein That Efficiently Elicits Neutralizing Antibodies , 2013, Journal of Virology.
[7] Victor M Corman,et al. Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection , 2013, The Lancet Infectious Diseases.
[8] P. Gastañaduy. Update: Severe Respiratory Illness Associated With Middle East Respiratory Syndrome Coronavirus (MERS-CoV)—Worldwide, 2012–2013 , 2013, American Journal of Transplantation.
[9] Clio,et al. First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013. , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[10] A. Fontanet,et al. Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission , 2013, The Lancet.
[11] Christian Drosten,et al. Commentary: Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group , 2013, Journal of Virology.
[12] Y. Guan,et al. Full-Genome Deep Sequencing and Phylogenetic Analysis of Novel Human Betacoronavirus , 2013, Emerging infectious diseases.
[13] H. Feldmann,et al. Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin , 2013, Scientific Reports.
[14] H. Feldmann,et al. Pneumonia from human coronavirus in a macaque model. , 2013, The New England journal of medicine.
[15] S. Perlman,et al. Complete Protection against Severe Acute Respiratory Syndrome Coronavirus-Mediated Lethal Respiratory Disease in Aged Mice by Immunization with a Mouse-Adapted Virus Lacking E Protein , 2013, Journal of Virology.
[16] Y. Guan,et al. Tropism of and Innate Immune Responses to the Novel Human Betacoronavirus Lineage C Virus in Human Ex Vivo Respiratory Organ Cultures , 2013, Journal of Virology.
[17] Christian Drosten,et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC , 2013, Nature.
[18] Chantal Reusken,et al. Human Betacoronavirus 2c EMC/2012–related Viruses in Bats, Ghana and Europe , 2013, Emerging infectious diseases.
[19] Markus Eickmann,et al. Human Cell Tropism and Innate Immune System Interactions of Human Respiratory Coronavirus EMC Compared to Those of Severe Acute Respiratory Syndrome Coronavirus , 2013, Journal of Virology.
[20] B. Sibal,et al. Evidence of person-to-person transmission within a family cluster of novel coronavirus infections, United Kingdom, February 2013. , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[21] Alexander E. Gorbalenya,et al. Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in Humans , 2012, mBio.
[22] R. Baric,et al. A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease , 2012, Nature Medicine.
[23] A. Osterhaus,et al. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. , 2012, The New England journal of medicine.
[24] M. Catchpole,et al. Novel coronavirus associated with severe respiratory disease: case definition and public health measures. , 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[25] T. Bestebroer,et al. Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. , 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[26] L. Enjuanes,et al. Molecular Characterization of Feline Infectious Peritonitis Virus Strain DF-2 and Studies of the Role of ORF3abc in Viral Cell Tropism , 2012, Journal of Virology.
[27] F. Pozo,et al. Detection of alpha and betacoronaviruses in multiple Iberian bat species , 2011, Archives of Virology.
[28] N. Van Rooijen,et al. Cell-Type-Specific Type I Interferon Antagonism Influences Organ Tropism of Murine Coronavirus , 2011, Journal of Virology.
[29] I. Sola,et al. Coronavirus Gene 7 Counteracts Host Defenses and Modulates Virus Virulence , 2011, PLoS pathogens.
[30] S. Goebel,et al. Accessory Protein 5a Is a Major Antagonist of the Antiviral Action of Interferon against Murine Coronavirus , 2010, Journal of Virology.
[31] Jincun Zhao,et al. Immunization with an attenuated severe acute respiratory syndrome coronavirus deleted in E protein protects against lethal respiratory disease , 2010, Virology.
[32] S. Perlman,et al. Coronaviruses post-SARS: update on replication and pathogenesis , 2009, Nature Reviews Microbiology.
[33] R. Johnston,et al. Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice , 2008, Proceedings of the National Academy of Sciences.
[34] R. Baric,et al. A Live Attenuated Severe Acute Respiratory Syndrome Coronavirus Is Immunogenic and Efficacious in Golden Syrian Hamsters , 2008, Journal of Virology.
[35] S. Perlman,et al. Pathogenicity of severe acute respiratory coronavirus deletion mutants in hACE-2 transgenic mice , 2008, Virology.
[36] Krishna Shankara Narayanan,et al. Severe Acute Respiratory Syndrome Coronavirus nsp1 Suppresses Host Gene Expression, Including That of Type I Interferon, in Infected Cells , 2008, Journal of Virology.
[37] C. Peters,et al. Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV , 2007, Vaccine.
[38] R. Baric,et al. Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease , 2007, Virus Research.
[39] Jianjun Chen,et al. Immune responses against severe acute respiratory syndrome coronavirus induced by virus-like particles in mice , 2007, Immunology.
[40] R. Baric,et al. Severe Acute Respiratory Syndrome Coronavirus Evades Antiviral Signaling: Role of nsp1 and Rational Design of an Attenuated Strain , 2007, Journal of Virology.
[41] L. Enjuanes,et al. Absence of E protein arrests transmissible gastroenteritis coronavirus maturation in the secretory pathway , 2007, Virology.
[42] P. Woo,et al. Comparative Analysis of Twelve Genomes of Three Novel Group 2c and Group 2d Coronaviruses Reveals Unique Group and Subgroup Features , 2006, Journal of Virology.
[43] P. Palese,et al. Severe Acute Respiratory Syndrome Coronavirus Open Reading Frame (ORF) 3b, ORF 6, and Nucleocapsid Proteins Function as Interferon Antagonists , 2006, Journal of Virology.
[44] K. Subbarao,et al. A Severe Acute Respiratory Syndrome Coronavirus That Lacks the E Gene Is Attenuated In Vitro and In Vivo , 2006, Journal of Virology.
[45] S. Alonso,et al. Construction of a Severe Acute Respiratory Syndrome Coronavirus Infectious cDNA Clone and a Replicon To Study Coronavirus RNA Synthesis , 2006, Journal of Virology.
[46] L. Enjuanes,et al. Recovery of a Neurovirulent Human Coronavirus OC43 from an Infectious cDNA Clone , 2006, Journal of Virology.
[47] R. Brunham,et al. Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus. , 2006, The Journal of general virology.
[48] Y. Zhang,et al. Immunogenicity and protective efficacy in monkeys of purified inactivated Vero-cell SARS vaccine , 2005, Vaccine.
[49] M. Reiter,et al. A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses , 2005, Vaccine.
[50] R. Baric,et al. Severe Acute Respiratory Syndrome Coronavirus Group-Specific Open Reading Frames Encode Nonessential Functions for Replication in Cell Cultures and Mice , 2005, Journal of Virology.
[51] L. Wen,et al. Immunogenicity, safety, and protective efficacy of an inactivated SARS-associated coronavirus vaccine in rhesus monkeys , 2005, Vaccine.
[52] L. Enjuanes,et al. The Nucleoprotein Is Required for Efficient Coronavirus Genome Replication , 2004, Journal of Virology.
[53] Lili Kuo,et al. The Small Envelope Protein E Is Not Essential for Murine Coronavirus Replication , 2003, Journal of Virology.
[54] S. Alonso,et al. Engineering the Transmissible Gastroenteritis Virus Genome as an Expression Vector Inducing Lactogenic Immunity , 2003, Journal of Virology.
[55] I. Sola,et al. Transmissible gastroenteritis coronavirus gene 7 is not essential but influences in vivo virus replication and virulence , 2003, Virology.
[56] P. Rottier,et al. Coronaviruses Maintain Viability despite Dramatic Rearrangements of the Strictly Conserved Genome Organization , 2002, Journal of Virology.
[57] Javier Ortego,et al. Generation of a Replication-Competent, Propagation-Deficient Virus Vector Based on the Transmissible Gastroenteritis Coronavirus Genome , 2002, Journal of Virology.
[58] P. Rottier,et al. The Group-Specific Murine Coronavirus Genes Are Not Essential, but Their Deletion, by Reverse Genetics, Is Attenuating in the Natural Host , 2002, Virology.
[59] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[60] J. M. González,et al. Engineering the largest RNA virus genome as an infectious bacterial artificial chromosome. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[61] S. An,et al. Induction of Apoptosis in Murine Coronavirus-Infected Cultured Cells and Demonstration of E Protein as an Apoptosis Inducer , 1999, Journal of Virology.
[62] K. Wang,et al. Complete nucleotide sequence of two generations of a bacterial artificial chromosome cloning vector. , 1997, BioTechniques.
[63] B. Birren,et al. Cloning and stable maintenance of 300-kilobase-pair fragments of human DNA in Escherichia coli using an F-factor-based vector. , 1992, Proceedings of the National Academy of Sciences of the United States of America.